Sensitive, Noninvasive Platform Detects Circulating Tumor Cells in Melanoma Patients

Scientists have created a laser-based platform that can quickly and noninvasively screen large quantities of blood in patients with melanoma to detect circulating tumor cells (CTCs) - a precursor to deadly metastases.